ag-1296 has been researched along with ascorbic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, YZ; Han, JX; Luan, J; Zhang, GL; Zhang, YY; Zhou, XY | 1 |
1 other study(ies) available for ag-1296 and ascorbic acid
Article | Year |
---|---|
Platelet-derived growth factor receptor kinase inhibitor AG-1295 promotes osteoblast differentiation in MC3T3-E1 cells via the Erk pathway.
Topics: Alkaline Phosphatase; Animals; Ascorbic Acid; Blotting, Western; Cell Differentiation; Cell Line; Collagen Type I; Collagen Type I, alpha 1 Chain; Core Binding Factor Alpha 1 Subunit; Dexamethasone; Dose-Response Relationship, Drug; Gene Expression Regulation; Glycerophosphates; MAP Kinase Signaling System; Mice; Osteoblasts; Osteocalcin; Osteogenesis; Phosphorylation; Real-Time Polymerase Chain Reaction; Receptor, Platelet-Derived Growth Factor beta; Sp7 Transcription Factor; Transcription Factors; Tyrphostins | 2012 |